PureTech reports Seaport Therapeutics stake on Form 3
PureTech Health plc, through its subsidiary PureTech LYT, Inc., has filed an initial ownership report for Seaport Therapeutics, Inc. (SPTX).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
PureTech Health plc, through its subsidiary PureTech LYT, Inc., has filed an initial ownership report for Seaport Therapeutics, Inc. (SPTX). The filing shows indirect holdings of 302,479 shares of common stock and several series of preferred stock.
PureTech LYT, Inc. is the record holder of all reported securities, while PureTech Health plc ultimately controls voting and disposition through an intermediate LLC. The Series A-1, A-2 and B preferred shares are convertible into common stock at the holder’s election and will automatically convert into common stock upon the closing of Seaport’s initial public offering, for no additional consideration.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
PureTech Health plc, PureTech LYT, Inc.
Role
10% Owner | 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Series A-1 Preferred Stock | -- | -- | -- |
| holding | Series A-2 Preferred Stock | -- | -- | -- |
| holding | Series B Preferred Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Series A-1 Preferred Stock — 12,736,014 contracts (Indirect, See footnote);
Series A-2 Preferred Stock — 2,681,265 contracts (Indirect, See footnote);
Series B Preferred Stock — 965,255 contracts (Indirect, See footnote);
Common Stock — 302,479 shares (Indirect, See footnote)
Footnotes (2)
- F1. PureTech LYT, Inc. is the record holder of all of the securities reported in this Form 3. PureTech Health LLC is the sole owner of PureTech LYT, Inc. PureTech Health plc is the sole member of PureTech Health LLC, and has the power to direct the voting and disposition of securities held by PureTech LYT, Inc. and PureTech Health LLC.
- F2. The shares of Issuer's preferred stock have no expiration date and are convertible at the holder's election into Issuer's common stock. The preferred stock will automatically convert into shares of the Issuer's common stock, for no additional consideration, upon the closing of the Issuer's initial public offering.
Key Figures
Common Stock held: 302,479 shares
Series B Preferred underlying common: 965,255 shares
Series A-2 Preferred underlying common: 2,681,265 shares
+2 more
5 metrics
Common Stock held
302,479 shares
Indirect holdings reported on Form 3
Series B Preferred underlying common
965,255 shares
Indirect; convertible into common stock
Series A-2 Preferred underlying common
2,681,265 shares
Indirect; convertible into common stock
Series A-1 Preferred underlying common
12,736,014 shares
Indirect; convertible into common stock
Preferred conversion price
$0.0000 per share
Series A-1, A-2, B preferred into common
Key Terms
ten percent owner, preferred stock, convertible, initial public offering, +1 more
5 terms
ten percent owner financial
"PureTech Health plc and PureTech LYT, Inc. are each marked as a ten percent owner."
preferred stock financial
"The filing lists Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock."
Preferred stock is a type of ownership in a company that typically offers investors higher and more consistent dividend payments than common stock. Unlike regular shares, preferred stock usually doesn’t come with voting rights but provides a priority claim on the company’s assets and profits, making it a more stable and predictable investment option. This makes preferred stock attractive to those seeking steady income with lower risk.
convertible financial
"The shares of Issuer's preferred stock have no expiration date and are convertible at the holder's election into Issuer's common stock."
A convertible is a type of investment that starts as a loan or preferred stake (like a bond or preferred share) but can be exchanged for common shares of the company at a set price or under certain conditions. It matters to investors because it offers a mix of steady income and downside protection like a loan, plus the upside of stock ownership if the company does well—similar to holding a coupon that you can trade for a full ticket if the event becomes valuable.
initial public offering financial
"The preferred stock will automatically convert into shares of the Issuer's common stock, for no additional consideration, upon the closing of the Issuer's initial public offering."
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
indirect ownership financial
"All reported securities are held indirectly through PureTech LYT, Inc. with PureTech Health plc controlling voting and disposition."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does PureTech Health plc report in its Seaport Therapeutics (SPTX) Form 3?
PureTech Health plc reports an indirect ownership stake in Seaport Therapeutics through PureTech LYT, Inc. The filing lists common and multiple preferred share classes that can convert into common stock, outlining PureTech’s structured equity position ahead of Seaport’s initial public offering.
What preferred stock holdings in Seaport Therapeutics does PureTech disclose?
PureTech discloses indirect holdings of Series A-1, Series A-2 and Series B preferred stock in Seaport Therapeutics. These preferred shares are convertible into common stock at the holder’s election and are structured to automatically convert into common stock when Seaport’s initial public offering closes.
How is ownership of Seaport Therapeutics structured between PureTech entities?
All reported Seaport securities are held of record by PureTech LYT, Inc. PureTech Health LLC is the sole owner of PureTech LYT, Inc., and PureTech Health plc is the sole member of PureTech Health LLC, giving PureTech Health plc power over voting and disposition decisions.
What happens to Seaport’s preferred stock held by PureTech at the IPO closing?
According to the filing, Seaport’s preferred stock held indirectly by PureTech has no expiration and converts into common stock at the holder’s election. It will automatically convert into common stock, for no additional consideration, upon the closing of Seaport’s initial public offering.
AI-generated analysis. How Rhea-AI works. Not financial advice.
